Researchers created Compound 10 to block GRK2 enzyme aggregation and protect mitochondria in Alzheimer's disease.
Morning Overview on MSN
A new vitamin K-based compound just helped the brain regrow lost neurons in the lab — engineered straight at Alzheimer’s and Parkinson’s
Most drugs aimed at Alzheimer’s and Parkinson’s disease try to slow the damage. A small team at Japan’s Shibaura Institute of ...
While illegal for recreational use, psychedelic drugs are showing great promise as treatments for severe depression and anxiety, as well as alcohol addiction and other conditions. Some advocates and ...
Girolline, a compound extracted from the sea sponge Pseudaxinyssa cantharella, has been investigated for possible antitumor effects and also found to have anti-malarial effects. Now, researchers have ...
Researchers at WashU Medicine and Stanford University developed a compound that relieves pain in mice but doesn't affect the brain, thereby avoiding mind-altering side effects and abuse potential. The ...
New research in animal models show it's possible to create a compound that hits the same exact target as psychedelic drugs hit -- the 5-HT2A serotonin receptors on the surface of specific neurons -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results